CimCure

Description

CimCure develops cancer vaccines that target and destroy tumour blood-vessel networks using its proprietary Immune-Boost (iBoost) conjugate vaccine technology for use against solid tumours.

Related

• CytuvaxCytuvax develops therapeutic cancer vaccines and prophylactic vaccines against viral and bacterial pathogens using a depot-attached…
• OsivaxOsivax develops vaccines using its oligoDOM platform to elicit T-cell and B-cell immunity, producing clinical-stage vaccine candidates…
• ThelperThelper develops first-in-class antiviral antibody drug conjugates (ADCs) targeting virally encoded biomarkers in aggressive solid tumors…
• TareBioTareBio develops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment…
• BioNTechBioNTech develops immunotherapies and mRNA vaccines for cancer, infectious diseases and other serious illnesses, serving patients through…
• Fraunhofer Institute for Cell Therapy and ImmunologyFraunhofer IZI develops biomedical methods, materials, and products for therapies, vaccines, diagnostics, and extracorporeal treatments.
• RTsafeRTsafe builds personalized 3D-printed dosimetry phantoms and dosimetry services used to QA radiotherapy treatments, primarily for brain…
• Merck Cambridge Discovery ($MRK)Merck Cambridge Discovery develops medicines and vaccines through research, clinical trials, and publications, focusing on diseases…
• HALIXHALIX is a biologics CDMO offering process development and manufacturing for viral vectors, vaccines, recombinant proteins, and aseptic…
• CeraVxCeraVx develops ceramic microneedle array patches (CeraMaps) for intradermal delivery of vaccines, therapeutics, diagnostics and…
• Bavarian Nordic A/SBuilds vaccines for prevention and public health; used by travelers, healthcare providers and public health programs to protect against…
• Institut PasteurInstitut Pasteur conducts basic and translational life‑science research and develops vaccines, diagnostics and training programs for public…